## BACKGROUND. Peroneal neuropathies in patients with systemic cancer previously have been attributed to weight loss, but to the authors' knowledge other associated conditions have not been assessed, and the outcome of peroneal neuropathies in cancer patients has not been studied. ## METHODS. A
Toxoplasma serology in patients with malignant diseases of the reticuloendothelial system
β Scribed by Dr. Charles L. Vogel; Milford N. Lunde
- Publisher
- John Wiley and Sons
- Year
- 1969
- Tongue
- English
- Weight
- 396 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Outcome of Peroneal Neuropathies in Patients with Systemic Malignant Disease R ubin et al. recently published an article in Cancer on the relation between peroneal neuropathy and systemic malignant disease. 1 We would like to present some comments and additional data, based on our own experienc
## Abstract ## Objective To identify the prevalence of serologically active clinically quiescent (SACQ) patients in a cohort of 290 patients with systemic lupus erythematosus (SLE). We investigated if the presence of antiβdoubleβstranded DNA (antiβdsDNA) or antinucleosome (antiβNCS) antibodies dur